Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$1.67 - $2.55 $1,239 - $1,892
742 Added 94.4%
1,528 $3,000
Q4 2023

Feb 14, 2024

SELL
$1.67 - $2.49 $6,077 - $9,061
-3,639 Reduced 82.24%
786 $1,000
Q2 2023

Aug 10, 2023

BUY
$2.57 - $3.3 $6,437 - $8,266
2,505 Added 130.47%
4,425 $12,000
Q1 2023

May 15, 2023

SELL
$2.74 - $4.44 $6,704 - $10,864
-2,447 Reduced 56.03%
1,920 $5,000
Q4 2022

Jun 14, 2023

BUY
$3.89 - $8.57 $9,518 - $20,970
2,447 Added 127.45%
4,367 $18.8 Million
Q3 2022

Jun 14, 2023

BUY
$5.82 - $10.68 $14,241 - $26,133
2,447 Added 127.45%
4,367 $34.1 Million
Q2 2022

Jun 20, 2023

BUY
$4.58 - $8.72 $11,207 - $21,337
2,447 Added 127.45%
4,367 $24,000
Q1 2022

Jun 20, 2023

BUY
$8.6 - $15.48 $21,044 - $37,879
2,447 Added 127.45%
4,367 $37,000
Q1 2022

Mar 30, 2023

SELL
$8.6 - $15.48 $16,838 - $30,309
-1,958 Reduced 30.96%
4,367 $37,000
Q1 2022

May 12, 2022

SELL
$8.6 - $15.48 $16,838 - $30,309
-1,958 Reduced 30.96%
4,367 $38,000
Q4 2021

Jun 21, 2023

BUY
$12.51 - $22.75 $55,106 - $100,213
4,405 Added 229.43%
6,325 $98,000
Q3 2021

Jun 21, 2023

BUY
$17.43 - $24.34 $76,779 - $107,217
4,405 Added 229.43%
6,325 $134,000
Q3 2021

Mar 30, 2023

BUY
$17.43 - $24.34 $34,127 - $47,657
1,958 Added 44.84%
6,325 $134,000
Q3 2021

Nov 15, 2021

BUY
$17.43 - $24.34 $110,244 - $153,950
6,325 New
6,325 $134,000

Others Institutions Holding ERAS

About Erasca, Inc.


  • Ticker ERAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 122,147,000
  • Market Cap $310M
  • Description
  • Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...
More about ERAS
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.